Press Releases from DelveInsight Business Research LLP (4789 total)
Desmoid Tumors Pipeline Outlook Report 2025: Insights on Key Pharma Players, Mar …
DelveInsight's, "Desmoid Tumors Pipeline Insight 2025" report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Desmoid Tumors pipeline landscape. It covers the…
Sanfilippo Syndrome Pipeline Drugs Report 2025: Evaluating Novel Drug Candidates …
DelveInsight's, "Sanfilippo Syndrome Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Sanfilippo Syndrome pipeline landscape. It covers the…
Hunter Syndrome Pipeline Insights Report 2025: A Deep Dive into Emerging Therapi …
DelveInsight's, "Hunter Syndrome Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Hunter Syndrome pipeline landscape. It covers the…
Mucopolysaccharidosis Type I Pipeline Outlook Report 2025: Comprehensive Insight …
DelveInsight's, "Mucopolysaccharidosis Type I Pipeline Insight 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Mucopolysaccharidosis Type I pipeline landscape. It…
Sandhoff Disease Pipeline Drugs Report 2025: Exploring Breakthrough Therapies, E …
DelveInsight's, "Sandhoff Disease Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Sandhoff Disease pipeline landscape. It covers the…
Essential Thrombocythemia Pipeline Outlook Report 2025: Advances in Research, Tr …
DelveInsight's, "Essential Thrombocythemia Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Essential Thrombocythemia pipeline landscape. It covers the…
Alzheimer's Disease Pipeline Assessment Report 2025: Companies, Drugs in Develop …
DelveInsight's, "Alzheimer's disease Pipeline Insight, 2025" report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in Alzheimer's disease pipeline landscape. It covers the…
Hepatocellular Carcinoma Pipeline Drugs Report 2025: Current Trials, Key Pharma …
DelveInsight's, "Hepatocellular Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 90+ companies and 95+ pipeline drugs in Hepatocellular Carcinoma pipeline landscape. It covers the…
Cholangiocarcinoma Pipeline Drugs Report 2025: Innovations Shaping the Future of …
DelveInsight's, "Cholangiocarcinoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Cholangiocarcinoma pipeline landscape. It covers the Cholangiocarcinoma Pipeline…
B-Cell Lymphoma Pipeline Insights Report 2025: Latest Updates on Therapeutics an …
DelveInsight's, "B-cell Lymphoma Pipeline Insight, 2025" report provides comprehensive insights about 295+ companies and 300+ pipeline drugs in B-cell Lymphoma pipeline landscape. It covers the…
Bladder Cancer Pipeline Outlook Report 2025: Detailed Insights into Market Dynam …
DelveInsight's "Bladder Cancer Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers…
Asthma Pipeline Outlook Report 2025: Market Trends, Drug Development, and Clinic …
DelveInsight's "Asthma Pipeline Insight 2025" report provides comprehensive insights about 80+ companies and 90+ pipeline drugs in Asthma pipeline landscape. It covers the Asthma pipeline…
Liver Cancer Pipeline Drugs Report 2025: Companies, Drugs in Development, and Fu …
DelveInsight's "Liver Cancer Pipeline Insights 2025" report provides comprehensive insights about 70+ companies and 75+ pipeline drugs in Liver Cancer pipeline landscape. It covers the…
Relapsing Refractory Multiple Myeloma Pipeline Drugs Assessment 2025: Advances i …
DelveInsight's, "Relapsed/Refractory Multiple Myeloma Pipeline Insight, 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Relapsed/Refractory Multiple Myeloma pipeline landscape. It…
Vitiligo Pipeline Outlook 2025: Key Players, Innovations, and Market Outlook | D …
DelveInsight's, "Vitiligo Pipeline Insight, 2025" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in Vitiligo pipeline landscape. It covers the Vitiligo pipeline…
Diabetic Macular Edema Pipeline Drugs 2025: Emerging Therapies and Latest Clinic …
DelveInsight's "Diabetic Macular Edema Pipeline Insight 2025" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in the Diabetic Macular Edema pipeline landscape.…
Colorectal Cancer Pipeline Drugs in Development Signal Major Shifts in the Treat …
DelveInsight's, "Colorectal Cancer Pipeline Insight 2025" report provides comprehensive insights about 195+ companies and 200+ pipeline drugs in Colorectal Cancer pipeline landscape. It covers the…
Idiopathic Pulmonary Fibrosis Pipeline Clinical Trial Insights Reveal Breakthrou …
DelveInsight's, "Idiopathic Pulmonary Fibrosis Pipeline Insights 2025" report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It…
Small Cell Lung Cancer Pipeline Clinical Trials Highlight Promising Drugs in Dev …
DelveInsight's, "Small Cell Lung Cancer Pipeline Insight 2025" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in Small Cell Lung Cancer pipeline…
Myelofibrosis Pipeline Outlook 2025: Insights Into Therapies, Research, and Mark …
DelveInsight's, "Myelofibrosis Pipeline Insights 2025" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the Myelofibrosis pipeline…
Vascular Malformations Pipeline Outlook 2025: Insights Into Therapies, Research, …
DelveInsight's, "Vascular Malformations Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Vascular Malformations pipeline landscape. It covers the…
Systemic Sclerosis Pipeline Outlook 2025: Insights Into Therapies, Research, and …
DelveInsight's, "Systemic Sclerosis Pipeline Insight 2025" report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Systemic Sclerosis pipeline landscape. It covers the…
Polycystic Kidney Disease Pipeline Outlook 2025: Insights Into Therapies, Resear …
DelveInsight's, "Polycystic Kidney Diseases Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Polycystic Kidney Diseases pipeline landscape. It…
Chronic Obstructive Pulmonary Disease Treatment Market Size Report 2034: Insight …
DelveInsight's "Chronic Obstructive Pulmonary Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the COPD, historical and forecasted epidemiology…
Dry Eye Syndrome Treatment Market Size Report 2034: Insights Into Therapies, Res …
DelveInsight's "Dry Eye Disease Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the DED, historical and forecasted epidemiology as…
Major Depressive Disorder Pipeline Outlook 2025: Insights Into Therapies, Resear …
DelveInsight's "Major Depressive Disorder Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape.…
Pompe Disease Pipeline Outlook 2025: Insights Into Therapies, Research, and Mark …
DelveInsight's, "Pompe Disease Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pompe Disease pipeline landscape. It covers the…
Retinal Vein Occlusion Pipeline Outlook 2025: Insights Into Therapies, Research, …
DelveInsight's "Retinal Vein Occlusion Pipeline Insight 2025" report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in the Retinal Vein Occlusion pipeline landscape.…
Duchenne Muscular Dystrophy Pipeline Outlook 2025: Insights Into Therapies, Rese …
DelveInsight's "Duchenne Muscular Dystrophy Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Duchenne Muscular Dystrophy pipeline landscape.…
Microbiome Disease Pipeline Outlook 2025: Insights Into Therapies, Research, and …
DelveInsight's, "Microbiome Disease Pipeline Insights 2025" report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the…
Atopic Dermatitis Pipeline Outlook 2025: Insights Into Therapies, Research, and …
DelveInsight's, "Atopic Dermatitis Pipeline Insight, 2025" report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in Atopic Dermatitis pipeline landscape. It covers the…
Chronic Kidney Disease Pipeline Outlook 2025: Insights Into Therapies, Research, …
DelveInsight's, "Chronic Kidney Disease Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in the Chronic Kidney Disease pipeline landscape.…
Multiple Sclerosis Pipeline Outlook 2025: Insights Into Therapies, Research, and …
DelveInsight's, "Multiple sclerosis Pipeline Insight 2025" report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Multiple sclerosis pipeline landscape. It covers the…
ALK+ NSCLC Pipeline Outlook 2025: Insights Into Therapies, Research, and Market …
DelveInsight's, "ALK+ NSCLC Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK+ NSCLC pipeline landscape. It covers the…
Advanced Melanoma Pipeline Outlook 2025: Insights Into Therapies, Research, and …
DelveInsight's, "Advanced Melanoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the…
Adenoid Cystic Carcinoma Pipeline Outlook 2025: Insights Into Therapies, Researc …
DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It…
Acral Lentiginous Melanoma Pipeline Appears Robust With 3+ Key Pharma Companies …
DelveInsight's, "Acral Lentiginous Melanoma Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Acral Lentiginous Melanoma pipeline landscape. It…
HPK1 Inhibitors Pipeline Appears Robust With 8+ Key Pharma Companies Actively Wo …
DelveInsight's, "HPK1 inhibitors Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in HPK1 inhibitors pipeline landscape. It covers the…
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape.…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as…
Post-Traumatic Stress Disorder Pipeline Outlook Report 2025 | DelveInsight
DelveInsight's, "Post-Traumatic Stress Disorder (PTSD) Pipeline Insight, 2025," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Post-Traumatic Stress Disorder (PTSD) pipeline…
ALK+ NSCLC Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Approva …
DelveInsight's, "ALK+ NSCLC Pipeline Insight 2025" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK+ NSCLC pipeline landscape. It covers the…
Advanced Melanoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA …
DelveInsight's, "Advanced Melanoma Pipeline Insight 2025" report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Advanced Melanoma pipeline landscape. It covers the…
Adenoid Cystic Carcinoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDM …
DelveInsight's, "Adenoid Cystic Carcinoma Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Adenoid Cystic Carcinoma pipeline landscape. It…
Acral Lentiginous Melanoma Pipeline Outlook 2025: Clinical Trial Studies, EMA, P …
DelveInsight's, "Acral Lentiginous Melanoma Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Acral Lentiginous Melanoma pipeline landscape. It…
HPK1 Inhibitors Pipeline Outlook 2025: Clinical Trial Studies, EMA, PDMA, FDA Ap …
DelveInsight's, "HPK1 inhibitors Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in HPK1 inhibitors pipeline landscape. It covers the…
Embolic Protection Devices Market is expected to rise at a CAGR of 7.58% by 2032 …
The global embolic protection devices market was valued at USD 648.51 million in 2024 and is projected to reach USD 1,161.31 million by 2032, advancing…
Electrosurgical Devices Market is expected to rise at a CAGR of 6.64% by 2032, e …
The global electrosurgical devices market was valued at USD 8,520.99 million in 2023 and is projected to grow at a CAGR of 6.64% from 2024…
Go To Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
